rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2007-11-28
|
pubmed:abstractText |
Levosimendan, a novel inodilator, has been shown to improve hemodynamic function in patients with acute exacerbation of congestive heart failure. We wanted to determine the hemodynamic effects of levosimendan following ineffective conventional therapy (with catecholamines) in patients with cardiogenic shock following myocardial infarction.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0090-3493
|
pubmed:author |
pubmed-author:BuerkeMichaelM,
pubmed-author:BuerkeUteU,
pubmed-author:CarterJustin MJM,
pubmed-author:ChristophArndA,
pubmed-author:LemmHenningH,
pubmed-author:ProndzinskyRolandR,
pubmed-author:ReithSebastianS,
pubmed-author:RussMartin AMA,
pubmed-author:SöffkerGeroldG,
pubmed-author:SchlittAxelA,
pubmed-author:SwyterMichaelM,
pubmed-author:WegenerNikolasN,
pubmed-author:WerdanKarlK,
pubmed-author:WinklerMatthiasM
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2732-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17893627-Angioplasty, Balloon, Coronary,
pubmed-meshheading:17893627-Cardiotonic Agents,
pubmed-meshheading:17893627-Catecholamines,
pubmed-meshheading:17893627-Dobutamine,
pubmed-meshheading:17893627-Female,
pubmed-meshheading:17893627-Hemodynamics,
pubmed-meshheading:17893627-Humans,
pubmed-meshheading:17893627-Hydrazones,
pubmed-meshheading:17893627-Infusions, Intravenous,
pubmed-meshheading:17893627-Male,
pubmed-meshheading:17893627-Middle Aged,
pubmed-meshheading:17893627-Pyridazines,
pubmed-meshheading:17893627-Shock, Cardiogenic
|
pubmed:year |
2007
|
pubmed:articleTitle |
Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
|
pubmed:affiliation |
Department of Internal Medicine III, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Comment,
Research Support, Non-U.S. Gov't
|